Clinical Trial: A prospective, single-center, open-label real-world study of budesonide enteric-coated capsules in the treatment of primary IgA nephropathy (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-center, open-label real-world study of budesonide enteric-coated capsules in the treatment of primary IgA nephropathy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131870

Registration Time: 2026/09/07

Type: Interventional study

Primary Sponsor: Ningbo Medical Centre Lihuili Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342122

Published by HT Digital Content Services with permission from Health Daily Digest....